Company Analysis

Roivant Sciences Ltd. (ROIV)

Nasdaq: ROIV · Pharmaceutical Preparations · London · filing with the SEC since 2015
Grade5.3
◀ Past 6.1● Present 6.5▶ Future 3.6

The company now

Roivant Sciences Ltd. is classed by the SEC under Pharmaceutical Preparations (industry code 2834), based in London. In its latest annual figures on file, for the fiscal year ended 2026-03-31, it reported revenue of $8.3 million and a loss of $300 million (its filed statements).

From its filings and filed figures; the desk's account of it is not written yet.

The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.

SI Assistanton ROIV · research, not advice